Explain Otezla May Be Safer Than Methotrexate for Plaque Psoriasis

March 2015

You'll see two new treatment options for moderate to severe plaque psoriasis, Otezla (apremilast) and Cosentyx (secukinumab).

About 20% of psoriasis patients need systemic meds added to topicals.

Be aware of the extra interactions, side effects, and monitoring.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Vaccines Point Out One Child Will Die for Every 10 That Get Tetanus
Diabetes Suggest Saving Afrezza for Patients Who Balk at Mealtime Insulin Injections
Diabetes Feel More Comfortable Dispensing Metformin in STABLE Kidney Disease
Women's Health Suggest Saving Opioids for Severe Pain During Pregnancy
Respiratory & Allergy Tell Patients All OTC and Rx Nasal Steroids Work About the Same
Anticoagulants Suggest Avoiding Savaysa for A Fib if CrCl is OVER 95 mL/min
Rosacea Suggest Soolantra for Rosacea if Metronidazole Isn't Enough
Psoriasis Explain Otezla May Be Safer Than Methotrexate for Plaque Psoriasis
Eating Disorders Suggest Vyvanse for Adults Who Binge Eat More Than 3 Days Per Week
Readmissions Ask for Discharge Orders to Understand Med Changes During Hospitalization
Kidney Stones Suggest Doxazosin for Kidney Stones if Tamsulosin Isn't Available
New Drugs Watch for Dosing Confusion with Ceftolozane/Tazobactam
Infectious Diseases Consider Steroids for CAP Patients on the Floor